We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Economical Method of Gene Silencing

By Biotechdaily staff writers
Posted on 27 Jan 2004
An alternative, more efficient way to accomplish the specific inhibition of gene functions by means of RNAs has been developed.

Currently, small interfering (si) RNAs are the method of choice to "knockdown” the function of particular genes, thereby offering clues about which genes are responsible for the expression of a particular bodily function. More...
However, the application of these molecules has proven to be inefficient, their chemical synthesis is very expensive, and their use in high-throughput screening experiments is uneconomical. An alternative method of gene silencing has been developed by the nonprofit German Resource Center for Genome Research (RZPD, Berlin, Germany).

To use this method, RZPD first manufactured and verified gene-specific products for some 36,000 Unigene Clusters. These were represented by polymerase chain reaction (PCR) products, which were amplified using two gene-specific primers per gene, avoiding repetitive or conserved sequences. Then T7 promoters were added to convert these double stranded (ds)DNAs into dsRNAs by in vitro transcription. These long dsRNA molecules can be cut by Dicer or RNaseII (exonuclease II) into functional siRNAs. The final products are potent tools for the specific knockdown of genes, often superior to synthesized siRNA oligos.

RZPD is a service center for genomics and proteomics research. Based on one of the largest clone collections worldwide, it provides high quality research material, high throughput technology, and automation solutions for academic institutions as well as for industry. A wide variety of materials and services are available. No intellectual property is claimed by RZPD for results derived from the use of its material.




Related Links:
RZPD

New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
HPV Test
Allplex HPV28 Detection
New
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Photo courtesy of Adobe Stock

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.